Literature DB >> 16175855

Characterization and correction of distortions in stereotactic magnetic resonance imaging for bilateral subthalamic stimulation in Parkinson disease.

Carole Menuel1, Line Garnero, Eric Bardinet, Fabrice Poupon, Daniel Phalippou, Didier Dormont.   

Abstract

OBJECT: High-frequency stimulation of the subthalamic nucleus (STN) is effective for treating refractory idiopathic Parkinson disease (PD). In stereotactic conditions magnetic resonance (MR) imaging is used by many teams to perform preoperative targeting of the STN. The goal of this study was to analyze and correct the geometrically observed MR imaging acquisitions used for targeting of the STN.
METHODS: A dedicated phantom of known geometry was used. The authors calculated existing shifts between measured points and theoretically defined points on the same T1- and T2-weighted sequences used to target the STN. A shifting volume was built to correct the phantom images and images acquired preoperatively in 13 patients with PD. A quantitative study of the correction was conducted using the phantom images and acquisitions acquired in these patients. To quantify the distortion corrections, the authors segmented the lateral ventricles and calculated the overlap of the corrected and uncorrected values between T1 and T2 segmentation. The authors found that the distortions were greater in the direction of slice selection and frequency encoding and weaker on three-dimensional T1-weighted acquisitions. On T2-weighted acquisitions, the maximum shifts were 2.19 mm in the frequency-encoding direction and 3.81 mm in slice selection. The geometrical distortion was significantly reduced and smaller than pixel size after distortion correction. Assessment of the patients' scans showed that the mean ventricular overlap was 76% before and 94% after correction.
CONCLUSIONS: The authors found that significant distortions can be observed on T2-weighted images used to demonstrate the STN. These distortions can be corrected using appropriate software.

Entities:  

Mesh:

Year:  2005        PMID: 16175855     DOI: 10.3171/jns.2005.103.2.0256

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center.

Authors:  Shang-Ming Chiou; Yu-Chin Lin; Ming-Kuei Lu; Chon-Haw Tsai
Journal:  Neurol Sci       Date:  2014-11-14       Impact factor: 3.307

2.  Cross contrast multi-channel image registration using image synthesis for MR brain images.

Authors:  Min Chen; Aaron Carass; Amod Jog; Junghoon Lee; Snehashis Roy; Jerry L Prince
Journal:  Med Image Anal       Date:  2016-10-22       Impact factor: 8.545

3.  An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla.

Authors:  Aviva Abosch; Essa Yacoub; Kamil Ugurbil; Noam Harel
Journal:  Neurosurgery       Date:  2010-12       Impact factor: 4.654

4.  Automated optimization of subcortical cerebral MR imaging-atlas coregistration for improved postoperative electrode localization in deep brain stimulation.

Authors:  T Schönecker; A Kupsch; A A Kühn; G-H Schneider; K-T Hoffmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-27       Impact factor: 3.825

5.  Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.

Authors:  R Guillevin; C Menuel; S Taillibert; L Capelle; R Costalat; L Abud; C Habas; G De Marco; K Hoang-Xuan; J Chiras; J-N Vallée
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

6.  Using MDEFT MRI Sequences to Target the GPi in DBS Surgery.

Authors:  Andreas Nowacki; Michael Fiechter; Jens Fichtner; Ines Debove; Lenard Lachenmayer; Michael Schüpbach; Markus Florian Oertel; Roland Wiest; Claudio Pollo
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 7.  Neuroimaging and deep brain stimulation.

Authors:  D Dormont; D Seidenwurm; D Galanaud; P Cornu; J Yelnik; E Bardinet
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.